biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".. a little under 60% of these encounters resulted in hospitalization and of these, about 13% required intensive care..
.
letter exposes 22 lab animal deaths at uc berkeley from 2015 to 2017.